BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1526339)

  • 1. Lipoprotein glycation and its metabolic consequences.
    Lyons TJ
    Diabetes; 1992 Oct; 41 Suppl 2():67-73. PubMed ID: 1526339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-enzymatic glycosylation of lipoproteins in the pathogenesis of atherosclerosis in diabetics].
    Calvo C
    Rev Med Chil; 1997 Apr; 125(4):460-5. PubMed ID: 9460289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycation and oxidation: a role in the pathogenesis of atherosclerosis.
    Lyons TJ
    Am J Cardiol; 1993 Feb; 71(6):26B-31B. PubMed ID: 8434558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipoprotein glycation and glycoxidation: their importance in diabetes mellitus].
    Actis Dato SM; Rebolledo OR
    Medicina (B Aires); 2000; 60(5 Pt 1):645-56. PubMed ID: 11188909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipoproteins from patients with poorly controlled diabetes mellitus and "in vitro" glycation of lipoproteins enhance the transfer rate of cholesteryl ester from HDL to apo-B-containing lipoproteins.
    Passarelli M; Catanozi S; Nakandakare ER; Rocha JC; Morton RE; Shimabukuro AF; Quintão EC
    Diabetologia; 1997 Sep; 40(9):1085-93. PubMed ID: 9300246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein glyco-oxidation.
    Picard S
    Diabete Metab; 1995 Apr; 21(2):89-94. PubMed ID: 7621977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein glycation and its metabolic consequences.
    Lyons TJ; Jenkins AJ
    Curr Opin Lipidol; 1997 Jun; 8(3):174-80. PubMed ID: 9211066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified lipoproteins, cytokines and macrovascular disease in non-insulin-dependent diabetes mellitus.
    Lopes-Virella MF; Virella G
    Ann Med; 1996 Aug; 28(4):347-54. PubMed ID: 8862690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased glycation of plasma lipoproteins in diabetic cynomolgus monkeys.
    Wagner JD; Bagdade JD; Litwak KN; Zhang L; Bell-Farrow AD; Wang ZQ; Cefalu WT
    Lab Anim Sci; 1996 Feb; 46(1):31-5. PubMed ID: 8699816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum lipoprotein and atherogenicity--relationship with particle size and composition of low density lipoproteins, and their modifications by oxidation and glycation].
    Takeuchi N; Saheki S
    Rinsho Byori; 1995 Aug; 43(8):753-62. PubMed ID: 7474432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of glycation in the acceleration of low density lipoprotein (LDL) uptake into macrophages in patients with diabetes mellitus.
    Makita T; Tanaka A; Nakano T; Nakajima K; Numano F
    Int Angiol; 1999 Jun; 18(2):149-53. PubMed ID: 10424372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperglycemia, lipoprotein glycation, and vascular disease.
    Veiraiah A
    Angiology; 2005; 56(4):431-8. PubMed ID: 16079928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake and metabolism of lipoproteins from patients with diabetes mellitus type II by glomerular epithelial cells.
    Krämer-Guth A; Quaschning T; Pavenstädt H; Galle J; Nauck M; Baumstark MW; Schollmeyer P; März W; Wanner C
    Nephrol Dial Transplant; 1997 Jul; 12(7):1336-43. PubMed ID: 9249767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycation of apolipoprotein E impairs its binding to heparin: identification of the major glycation site.
    Shuvaev VV; Fujii J; Kawasaki Y; Itoh H; Hamaoka R; Barbier A; Ziegler O; Siest G; Taniguchi N
    Biochim Biophys Acta; 1999 Aug; 1454(3):296-308. PubMed ID: 10452964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycated LDL concentrations in non-diabetic and diabetic subjects measured with monoclonal antibodies reactive with glycated apolipoprotein B epitopes.
    Cohen MP; Lautenslager G; Shea E
    Eur J Clin Chem Clin Biochem; 1993 Nov; 31(11):707-13. PubMed ID: 7508270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic predisposition in multiple metabolic syndrome. Part 3. Metabolism of lipids, lipoproteins and apolipoproteins].
    Sobra J; Ceska R
    Cas Lek Cesk; 1999 Mar; 138(5):136-41. PubMed ID: 10376396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnosine and its constituents inhibit glycation of low-density lipoproteins that promotes foam cell formation in vitro.
    Rashid I; van Reyk DM; Davies MJ
    FEBS Lett; 2007 Mar; 581(5):1067-70. PubMed ID: 17316626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunctional lipoproteins from young smokers exacerbate cellular senescence and atherogenesis with smaller particle size and severe oxidation and glycation.
    Park KH; Shin DG; Cho KH
    Toxicol Sci; 2014 Jul; 140(1):16-25. PubMed ID: 24798380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoprotein impedes glycation of low-density lipoprotein.
    Younis NN; Soran H; Charlton-Menys V; Sharma R; Hama S; Pemberton P; Elseweidy MM; Durrington PN
    Diab Vasc Dis Res; 2013 Mar; 10(2):152-60. PubMed ID: 22890407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact and mechanism for oxidized and glycated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells.
    Shen GX
    Mol Cell Biochem; 2003 Apr; 246(1-2):69-74. PubMed ID: 12841345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.